Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults
NCT ID: NCT05113043
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2022-02-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke
NCT07247838
Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke
NCT04688138
Gut Microbiota in Acute Stroke Patients
NCT03934021
The Association of Gut Microbes and Their Metabolites With Post-stroke Depression
NCT05414227
Dynamic Changes of the Human Microbiome Predict the Risk of Poor Prognosis in Patients With Acute Ischemic Stroke: a Multi-center Study
NCT04978701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic stroke
Young patients who suffered from acute ischemic stroke within 12 hours for the first time before entry into the study.
No interventions assigned to this group
Hemorrhagic stroke
Young patients who suffered from acute hemorrhagic stroke within 12 hours for the first time before entry into the study.
No interventions assigned to this group
Healthy Controls
Healthy young people
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission within 12 hours
* Aged 18-45 years
Exclusion Criteria
* Combined with tumors, inflammatory bowel disease and other digestive system diseases
* Combined with serious life-threatening diseases or condition
* Any antibiotics, probiotics or prebiotic treatment within 3 months
* Deteriorate and die before collecting faecal samples
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 6th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hao Chen, MD, PhD
Associate Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lixia Xue, M.D., Ph.D.
Role: STUDY_DIRECTOR
Shanghai 6th People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai 6th People's Hospital
Shanghai, , China
Shanghai 6th People's Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hao Chen, M.D., Ph.D.
Role: primary
Lixia Xue, M.D., Ph.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-KY-112 (K)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.